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Background: According to cross-sectional and acute experimental evidence, reducing sitting 
time should improve cardio-metabolic health risk biomarkers. Furthermore, the improvements 
obtained may depend on whether sitting is replaced with standing or ambulatory activities. Based 
on data from the Stand Up Victoria multi-component workplace intervention, we examined this 
issue using compositional data analysis — a method that can examine and compare all activity 
changes simultaneously. 
Methods: Participants receiving the intervention (n=136 ≥0.6 full-time equivalent desk-based 
workers, 65% women, mean±SD age=44.6 ±9.1 years from seven worksites) were asked to 
improve whole-of-day activity by standing up, sitting less and moving more. Their changes in 
the composition of daily waking hours (activPAL-assessed sitting, standing, stepping) were 
quantified, then tested for associations with concurrent changes in cardio-metabolic risk (CMR) 
scores and 14 biomarkers concerning body composition, glucose, insulin and lipid metabolism. 
Analyses were by mixed models, accounting for clustering (3 months, n=105–120; 12 months, 
n=80–97).   
Results: Sitting reduction was significantly (p<0.05) associated only with lower systolic blood 
pressure at three months, and with CMR scores, weight, body fat, waist circumference, diastolic 
blood pressure, and fasting triglycerides, total/HDL cholesterol and insulin at 12 months. 
Significant differences between standing and stepping were only observed for systolic blood 
pressure and insulin; both favored stepping. However, replacing sitting with standing was 
significantly associated only with improvements in CMR scores, while replacing sitting with 
stepping was significantly associated with CMR scores and six biomarkers.  
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Conclusions: Improvements in several cardio-metabolic health risk biomarkers were 
significantly associated with sitting reductions that occurred in a workplace intervention. The 
greatest degree and/or widest range of cardio-metabolic benefits appeared to occur with long-
term changes, and when increasing ambulatory activities.  
Keywords: sedentary; compositional data analysis (CoDA); ambulation; intervention; 
biomarkers 
TRIAL REGISTRATION: ACTRN1211000742976  
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INTRODUCTION  1 
Increased risk of developing cardiovascular disease and diabetes (1), and elevated biomarkers of 2 
risk for these chronic diseases (2), have been observed with high volumes of sitting time, and 3 
especially sitting time accrued in a prolonged, continuous manner. Supporting the 4 
epidemiological evidence, laboratory studies have shown acute benefits to glucose, insulin, and 5 
lipid metabolism of interspersing long periods of sitting with even small amounts of activity (3-6 
5).  Accordingly, interventions to reduce sitting, especially in the workplace — a  key setting for 7 
addressing prolonged sitting time — have been advocated as a public-health strategy (6, 7). In 8 
particular, sit-stand workstations have emerged as effective tools in multi-component workplace 9 
sitting interventions (8) as their usage reduces sitting time by large volumes.  10 
 11 
By contrast with the clear evidence that such interventions can reduce sitting time, the evidence 12 
concerning whether they are likely to impart non-acute benefits to cardio-metabolic health is less 13 
clear, especially when sitting is primarily replaced with standing. Workplace sitting-reduction 14 
interventions that primarily increase standing (e.g., through installation of sit-stand desks) have 15 
shown benefits concerning lipid and glucose biomarkers, but inconsistently (9-11). Notably, thus 16 
far, only the sitting-reduction interventions that have increased stepping (e.g., by use of treadmill 17 
desks) have shown significant benefits to body weight or body composition (12, 13). The short-18 
term evaluations and insufficient sample sizes of most studies may explain the mixed findings. 19 
However, it is also possible that the potential cardio-metabolic benefits of reducing sitting in an 20 
intervention are inherently variable because participants can make a plethora of different 21 
behavior changes when reducing sitting. Potentially relevant considerations include the volume 22 
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of sitting reduction, the activities replacing sitting (e.g., standing versus ambulatory activities), 23 
and any compensatory activity changes that may or may not occur (14).  24 
 25 
Recently, compositional data analysis (CoDA) has been used to simultaneously examine all 26 
activities occupying a 24-hour day and test them in relation to cardio-metabolic biomarkers (15). 27 
The study findings revealed that some biomarkers, notably those pertaining to glucose 28 
metabolism, improve significantly when increasing light activity at the expense of sedentary time 29 
(15). Importantly, CoDA is a valid method for examining data that sum to a fixed total, such as 30 
24 hours (15) and it can be applied to evaluate all of the changes in activity that occur during an 31 
intervention simultaneously, and test these in relation to changes in cardio-metabolic biomarkers. 32 
To our knowledge, CoDA has not been applied in this context, nor to the examination of 33 
standing as a separate component from ambulatory light activities. Using CoDA, we therefore 34 
examined the associations of short- and long-term (3- and 12-month) changes in daily time use 35 
with concurrent changes in cardio-metabolic biomarkers, within participants receiving the Stand 36 
Up Victoria intervention. 37 
 38 
METHODS 39 
The Stand Up Victoria cluster-randomized trial was registered with the Australian New Zealand 40 
Clinical Trials register (ACTRN12611000742976). The Alfred Health Human Ethics Committee 41 
(Melbourne, Australia) granted ethical approval. Participants provided written consent. The 42 
study was conducted in accordance with the CONSORT guidelines for cluster-randomized trials 43 
(http://www.consort-statement.org/). Details are published elsewhere concerning the study 44 
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protocol (16), the measures used, development and pilot testing (10, 17), evaluation of the main 45 
activity outcomes (18) and the secondary cardio-metabolic biomarker outcomes(19). 46 
 47 
Setting and participants 48 
Teams from study worksites that were at least one kilometre apart were identified and recruited 49 
from a single organization, then were randomized to the intervention (n=7 sites, n=136 workers) 50 
or control (n=7 sites, n=95 workers) condition. Eligibility criteria for individual participants in 51 
the selected teams were: aged 18–65 years; not pregnant; ambulatory; speaks English; capable of 52 
standing or sitting for ≥10 minutes continuously; and, working ≥0.6 full time equivalent with 53 
designated access to a telephone, internet, and desk. Participants and study staff were not blinded 54 
to group allocation. The present study evaluates only the intervention participants. 55 
 56 
Intervention 57 
The Stand Up Victoria intervention consisted of organizational support (senior management 58 
support, a team champion who sent emails containing the intervention messages); environmental 59 
modification (sit-stand workstations); and, individual health coaching (including goal setting and 60 
tracking). The intervention was tapered over 12 months with intensive components (e.g., health 61 
coaching, team champion intervention) ceasing after 3 months. It primarily targeted reductions in 62 
workplace sitting time, especially sitting accrued for ≥30 minutes at a time continuously. The 63 
main message was to “Stand Up, Sit Less, Move More”. The intervention encouraged 64 
participants to replace part of their sitting across the entire day with standing and stepping, by 65 
standing at their workstation for at least an hour a day, and by using a variety of self-selected 66 
strategies, which might target standing, stepping or both. Evaluation of the study’s activity 67 
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outcomes previously revealed that, net of control, the intervention on average produced 68 
moderately large effects on reduced sitting and increased standing (≈ 80 min/day at 3-months 69 
and ≈ 40 min/day at 12-months) with no significant effect on stepping (-6 min/day at 12-months) 70 
(18). These effects were established across the entire waking day (i.e., at work and outside of 71 
work, considering the entire week rather than just workdays). Cardio-metabolic biomarker 72 
outcomes, net of control, showed a significant improvement in overall cardio-metabolic risk and 73 
fasting glucose at 12 months, and non-significant (but typically favorable) effects on the other 74 
biomarkers (19).  75 
 76 
Data collection and measures 77 
Measurements were at baseline, three months into the intervention (upon completion of the 78 
individual-level health coaching and champion emails) and at 12 months, and included an onsite 79 
assessment of biomarkers and an activity monitoring assessment. Further participant 80 
characteristics were assessed using Oonline questionnaires (LimeService: 81 
www.limeservice.com) assessed most other participant characteristics. 82 
 83 
Cardio-metabolic biomarker outcomes 84 
The collection of these biomarkers is described in detail elsewhere(19), along with their changes 85 
over the course of the intervention. The cardio-metabolic biomarkers examined were: systolic 86 
blood pressure, diastolic blood pressure, weight, fat mass (kg, % of bodyweight), waist 87 
circumference, fasting triglycerides, high-density lipoprotein (HDL)- and low density lipoprotein 88 
(LDL)- cholesterol, total/HDL cholesterol ratio, glucose, insulin, insulin sensitivity (%S) and 89 
steady state beta cell function (%B)  as calculated using the homeostatic model assessment 90 
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(HOMA2) online calculator (https://www.dtu.ox.ac.uk/homacalculator/) version 2.2.3  and an 91 
overall cardio-metabolic risk (CMR) score. CMR scores (20) were calculated by first log10 92 
transforming and normalizing (mean/SD) the relevant biomarkers, then by taking a weighted 93 
average of their values:1/5∙waist circumference + 1/5∙triglycerides -+ 1/5∙HDL-cholesterol + 94 
1/5∙fasting glucose + 1/5∙ mean of systolic and diastolic blood pressure.  Changes in the 95 
biomarkers were calculated as follow up score minus baseline score.  96 
 97 
Activity measures 98 
Activity was measured by the highly accurate (21) and responsive (22) activPAL3
TM
 activity 99 
monitor (PAL Technologies Limited, Glasgow, UK; minimum version 6.3.0). The waterproofed 100 
monitor was secured onto the right anterior thigh with a hypoallergenic patch at the onsite 101 
assessment. Each participant was asked to wear the monitor continuously (24 h/day) for the 102 
following seven days, and to record the following times daily in a diary: starting and finishing 103 
work; waking up; going to sleep (“lights out”); removing and re-attaching the monitor. Monitor 104 
data were processed as reported in the primary outcomes paper (18). Though daily activities can 105 
be classified in many ways, we subdivided time use by activity classifications consistent with the 106 
intervention and measurement tool: sitting, standing, and stepping (during waking hours, while 107 
wearing the monitor) and “other” time (non-wear time and time in bed).  108 
 109 
Statistical analyses 110 
Analyses were performed in STATA version 13 (STATACorp, College Station, Texas, US) and 111 
R version 3.3.0, using the packages “compositions” (“acomp” framework) “nlme” and 112 




Quantifying activity and activity change compositionally 115 
 116 
We used compositional methods, which have been outlined as applied to cross-sectional physical 117 
activity and sedentary behavior data by Chastin et al (15). The total 24-hour day was divided 118 
across four activities (stepping, standing, sitting, “other”). Sleep, other time in bed and non-wear 119 
time comprised “other” time (i.e., 24 hours minus monitored waking hours). CoDA’s property of 120 
“sub-compositional coherence” means that the exclusion of irrelevant activities does not 121 
adversely affect results (23). The analysis includes only the sub-composition of activities that 122 
comprise waking hours (stepping, standing, sitting); i.e., the composition of waking hours. 123 
“Other” time was excluded in order to reduce the number of dimensions and provide efficient 124 
estimates. This decision seemed to be reasonable since the “other” time was not targeted by the 125 
intervention and did not change much over time at the group level or for individuals. At baseline, 126 
three months, and 12 months, compositions were calculated using the R function “acomp”. No 127 
method was required to address the problem of zero time use, as all participants spent some time 128 
in every time-use category at each assessment. Compositional changes [Step∆, Stand∆, Sit∆] were 129 
then measured by Aitchison’s perturbation method (23, 24). The ratios of each component in the 130 









] for 12-month changes from 131 
baseline, were calculated and were then divided by the sum total of these ratios.  An equal 132 
composition of these three activities at baseline and follow up would result in a compositional 133 
change of [1/3,1/3,1/3]. Compositional changes were plotted as ternary diagrams (Figure 1), with 134 
key some guide values marked: no change; average sitting reduces by 1 h/16h day replaced with 135 
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either all stepping, all standing, or half of each; and, the average sitting reduces by 2 h/16h day 136 
replaced entirely with standing.  137 
 138 
Quantifying associations of activity changes with biomarker changes 139 
The associations of activity changes with biomarker changes were examined as mixed models 140 
(“lme” function), with a random intercept for cluster, and fixed effects for changes in the activity 141 
composition [Step∆, Stand∆, Sit∆]. Short- and long-term changes were examined separately. 142 
Briefly, we used an isometric log-ratio transformation (i.e., “ilr” function) to measure the 143 
compositional change as two parameters (z1 and z2).  These parameters are orthogonal and can 144 
therefore be safely included together as independent variables in the mixed models (15, 23). The 145 
isometric log-ratio transformation can be performed from a number of perspectives. The primary 146 
perspective we used allows for the effect of a decrease in the parameter z1 on biomarkers to 147 
indicate the effects of making sitting a smaller proportion of the waking day. These effects are 148 
estimated while controlling for shifts in the remaining non-sitting time between standing and 149 
stepping, the effect of which is measured as the parameter z2. The transformation was as 150 
follows: 151 






) [𝐸𝑞. 1]  






) [𝐸𝑞. 2] 
 152 
In addition, we presented selected estimates for the z2 parameter calculated from different 153 
perspectives that indicate the effects of shifts in non-stepping time between sitting and standing 154 
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(more standing less sitting), and the shifts in non-standing time between sitting and stepping 155 
(more stepping less sitting). Although the direction and significance of the parameters can be 156 
used to understand the findings, the clinical relevance of the coefficients is not straightforward. 157 
Estimates were presented partially standardized, with biomarker changes all expressed as a 158 
number of baseline standard deviations, so that the relative effects on the different biomarkers 159 
can be compared. To better understand the results, tertiles of predicted improvement (most 160 
improved/least worsened to least improved/most worsened) were plotted across changes in the 161 
composition that participants made (as presented in Figure 2). Also, to better indicate effect 162 
sizes, the predicted mean improvement was calculated across a range of standing and stepping 163 
changes in the composition that culminate in reducing sitting to recommended levels of 50% 164 
(25). Consistent with the use of CoDA methods, our analyses did not adjust for total waking 165 
hours (or wear time). Instead, a sensitivity analysis using the composition of all waking 24 hours 166 
was conducted to verify that excluding changes in “other” time was reasonable (and by 167 
implication that ignoring the total amount of waking hours was reasonable). 168 
 169 
RESULTS 170 
Baseline characteristics of intervention participants are shown in Supplemental Table 1. Relevant 171 
data on short- and long-term changes were available from 105–120 participants (77–88%) and 172 
80–97 (59–71%), respectively. Generally, those who provided data were similar to those who 173 
dropped out, with the exception being that more women than men dropped out during the 174 
intervention, which shifted anthropometric biomarkers in directions expected for a group 175 




Activity composition 178 
Activity outcomes have been reported previously (18). Considering activity as a composition of 179 
daily time use, the intervention group’s daily activity was very high in sitting, low in standing 180 
and very low in stepping both at baseline [65.4%, 24.1%, 10.5%] and to a lesser extent at 12 181 
months [60.4%, 29.5%, 10.1%] (Supplemental Figure 1), corresponding to a mean 12-month 182 
change of [0.30, 0.39, 0.31]. Figure 1 is a ternary plot of the 12-month changes, with each corner 183 
indicating a complete change towards that activity (from 0% to 100% of waking hours) and with 184 
the centre indicating no change. Individual changes made by participants were highly variable. 185 
The mean change in the composition was statistically significant (with the 95% confidence 186 
region excluding no change) and was very close to the point indicating a drop in mean baseline 187 
sitting of 1 hour/16 hours awake, when sitting is replaced exclusively with standing.  188 
 189 
Changes in the activity composition with changes in biomarkers 190 
Three-month sitting reductions were significantly associated only with changes in systolic blood 191 
pressure (p=0.039), with the direction of associations indicating sitting reduction to be beneficial 192 
(Tables 1–2). Long-term (12-month) sitting reductions were significantly associated with 193 
improvements in CMR, triglycerides, total/HDL cholesterol ratio, diastolic blood pressure, 194 
weight and body fat, waist circumference and insulin, and had a borderline significant (p=0.063) 195 
association with improved insulin sensitivity (Tables 3–4).  196 
 197 
In terms of the forms of sitting reductions associated with biomarker changes, overall CMR 198 
scores improved significantly with sitting-standing substitutions (p=0.031) and with sitting-199 
stepping substitutions (p=0.028) without a statistically significant difference between standing 200 
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and stepping (p=0.240). By contrast, for fasting insulin and insulin sensitivity (HOMA-S), 201 
stepping was significantly better than standing as a sitting replacement (p=0.006 and 0.032). No 202 
significant effect on these biomarkers was seen of replacing sitting with standing (p=0.889 and 203 
0.943) whereas replacing sitting with stepping was associated with significant benefit (p=0.006 204 
and 0.029). Figure 2 displays the results graphically. CMR improvements were seen when 205 
reducing the contribution of sitting to the overall waking day. At some levels of sitting change, 206 
there was patterning whereby more CMR improvement was seen when the remaining time use 207 
was shifted more towards stepping rather than standing (i.e., from left to right across the graph), 208 
but this was not evident with the largest sitting reductions. All of the participants in the most 209 
improved tertile of CMR had made sitting reductions. Figure 2b shows that the degree of 210 
improvement that occurred at all levels of sitting change appeared dependent on how much of 211 
the remaining (non-sitting) time use shifted towards stepping (most beneficial) versus standing.  212 
 213 
For the other outcomes that had significantly improved with long-term sitting reduction (i.e., 214 
triglycerides, total/HDL cholesterol, diastolic blood pressure, weight, body fat (kg and %) and 215 
waist circumference), it was not clear whether or not these improvements depended on sitting 216 
being replaced with ambulatory activities. Suggestive that either standing or ambulation can 217 
improve these outcomes, there was no significant difference whether sitting was replaced with 218 
standing or stepping. However, the effects on these outcomes observed for replacing sitting with 219 
standing did not reach statistical significance, while replacing sitting with stepping was 220 
significantly associated with improved total/HDL cholesterol ratio (p=0.045), diastolic blood 221 
pressure (p=0.027), and fat mass (kg and %, p=0.034 and 0.022). In addition to statistical 222 
significance, the direction of the results, and the patterning of biomarker changes across activity 223 
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as plotted in Supplemental Figures 2–5, are informative. These were consistent with these 224 
biomarkers improving somewhat by substituting sitting with standing and improving slightly 225 
more by substituting sitting with stepping. Supplemental Table 2 shows the estimated mean 12-226 
month changes in cardio-metabolic outcomes when reducing baseline mean sitting (65.4%) to 227 
desirable levels (50%) via various replacement strategies. Moderate to strong improvements 228 
(0.5–0.8 SD) were seen for many outcomes but only with substantial increases in ambulation. In 229 
order to see a small improvement in mean biomarkers (0.2 SD), only a small percentage of the 230 
sitting reduction needed be achieved by increasing ambulatory activities for lipids and blood 231 
pressure (20% or less), for insulin (21%) and for some of the adiposity indicators (waist 232 
circumference and body fat percentage). The requirement for ambulation was higher for the other 233 
outcomes, ranging from 30% to 68% of the sitting replacement.   234 
 235 
Changes in the amount of “other” time relative to sitting standing and stepping were only 236 
significantly associated with systolic blood pressure at 12 months, and triglycerides, HDL 237 
cholesterol and HOMA-S at three months (Supplemental Table 3). For all these outcomes, the 238 
conclusions concerning reducing sitting relative to standing and stepping, and shifts between 239 
standing and stepping were no different whether examining all hours or only waking hours.  240 
 241 
DISCUSSION 242 
Previously, we showed the Stand Up Victoria workplace sitting-reduction intervention 243 
predominantly reduced sitting by increasing standing (18), and was effective in the long term for 244 
improving fasting glucose and an overall CMR score, net of control (19). The present study 245 
extends from these findings to understand how the various activity changes that intervention 246 
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participants made were associated with concurrent biomarker changes, using a novel application 247 
of compositional analysis. We found that sitting reduction was associated with significant 248 
improvements in the biomarkers of cardiovascular and metabolic health across all of the areas 249 
examined (glucose and insulin metabolism, lipid metabolism, blood pressure, body composition). 250 
To varying degrees, the various benefits appeared to depend on the type of sitting reduction (i.e., 251 
whether sitting was replaced with standing or with stepping).  252 
 253 
Both the previously reported outcomes of the workplace sitting intervention (19) and the present 254 
findings may indicate the need for long-term intervention to improve biomarkers via sitting 255 
reduction. We saw many significant associations of activity changes with biomarker changes 256 
over a 12-month timeframe, and very few over a three-month period. While this could be a 257 
chance finding, it could also reflect a physiological requirement for long-term behavior change in 258 
order to improve these biomarkers. Either way, it appears prudent to investigate long-term 259 
effects rather than infer them from short-term interventions, where benefits may be missed.    260 
 261 
Our CMR findings showed that cardio-metabolic biomarker improvement can occur when 262 
replacing sitting time with non-ambulatory activities. However, findings for the individual 263 
biomarkers suggested the degree and/or range of cardio-metabolic biomarker improvements may 264 
be greater when replacing sitting with ambulation than with standing. Fasting insulin and 265 
HOMA-S improved significantly more by replacing sitting with stepping than with standing. 266 
Some of the findings showed seemingly conflicting results whereby standing was neither 267 
significantly beneficial, nor significantly inferior to stepping. This apparent conflict is potentially 268 
explained by the study’s sample size providing insufficient precision to distinguish standing from 269 
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either sitting or stepping, with standing having an impact that was more beneficial than sitting 270 
but less beneficial than stepping. Larger RCTs or meta-analyses may yield further insights as to 271 
potential benefits of replacing sitting with standing within field-based sitting-reduction 272 
interventions.  Cross-sectionally, in isotemporal analyses, reallocating time use away from sitting 273 
towards additional standing has shown significant beneficial associations with triglycerides, 274 
HDL cholesterol, total/HDL cholesterol ratio and fasting glucose though not with weight or waist 275 
circumference (26). In addition to the outcomes that appear important from the existing 276 
literature, our findings suggest that key biomarkers that might be important to collect when 277 
evaluating interventions similar to Stand Up Victoria are: those comprising CMR scores; those 278 
showing the greatest response to substituting sitting specifically with standing (i.e., waist 279 
circumference, fasting glucose, triglycerides and diastolic blood pressure, whose coefficients for 280 
sitting versus standing were largest  at ≈0.3 to 0.6 SD); and, the biomarkers that showed the most 281 
predicted improvement when reducing sitting to desirable levels (25) without large changes to 282 
stepping (i.e., lipids, blood pressure, insulin, waist circumference and body fat).   283 
 284 
Consistent with our findings, the underlying biological mechanisms would also tend to suggest 285 
that both standing and stepping should be beneficial, but with the greatest benefit for stepping. 286 
The added benefit for glycemic control associated with transitions to stepping compared with 287 
transitions to standing may reflect greater muscle and/or metabolic activity in general (27, 28), or 288 
the comparatively higher energy demand associated with activation of fast-twitch glycolytic 289 
fibres (29, 30). This contrasts with the lesser glycemic benefit of transitions to standing which 290 
involve a comparatively lower energy requirement and engagement of oxidative fibres, favoring 291 
fat metabolism (29, 30). Broadly, the findings aligned with recent acute experimental studies in 292 
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overweight adults that have sometimes indicated greater improvements in postprandial glucose 293 
and insulin responses (4, 31, 32) by interrupting sitting with intermittent ambulation compared 294 
with standing breaks. Similarly, cross-sectional isotemporal analyses have also showed stronger 295 
effects on a range of cardio-metabolic biomarkers when sitting time is reallocated to additional 296 
stepping rather than standing (26). Notably “stepping” is  an amalgamation of various 297 
ambulatory activities, and the stepping findings are therefore reflective of the “averagetypical 298 
mix” of the various ambulatory activities that were performed by the participants of the Stand Up 299 
Victoria intervention, which had a predominant focus on light-intensity activity. Within the 300 
stepping category, effects of running are likely greater than walking slowly, for example. 301 
Similarly, effects of sitting are reflective of the “typical mix” of sitting for this population; it is 302 
possible that certain types of sitting (e.g., sitting in long bouts, sitting after lunch) are more 303 
deleterious than others.  304 
 305 
Strengths of the study include the evaluation of the short- and long-term effects on objectively 306 
assessed biomarkers alongside accurately and objectively measured behaviors, with good study 307 
retention especially in the short term. A novel element was that this intervention that targeted 308 
whole-of-day behavior changes was examined with analytic methods suited to such data. A key 309 
limitation was that the study was not powered a priori for this secondary analysis and showed 310 
evidence of limited power and precision (e.g., the wide margins of error around predicted mean 311 
values). We did not adjust for co-occurring changes in the intervention (e.g., in dietary intake) as 312 
these are potentially attributable to the intervention; however, the changes may have been 313 
coincidental, and therefore our results may be subject to confounding. It appeared unlikely that 314 
the findings were strongly affected by unexamined activities or variation in total waking hours. 315 
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However, this is impossible to verify without accurate and detailed measures (e.g., high-quality 316 
sleep, time in bed unable to sleep etc.) or knowledge of activity during unobserved time. Another 317 
limitation was that the study took neither measures of post-prandial metabolism nor continuous 318 
biomarker measurements in the behavior setting (e.g., by continuous glucose monitoring or 24-319 
hour ambulatory blood pressure monitoring). A focus on the postprandial state may be especially 320 
important for interventions targeting not only whole-of-day changes but also workplace changes, 321 
since the postprandial periods after lunch and other meals are often spent at work. 322 
Generalizability is limited, as participants were recruited non-randomly from a single 323 
organization and there was some evidence of a tendency to disproportionately lose women to 324 
follow-up. Also, our sample was a general population of workers; effects may also differ within 325 
clinical populations.  326 
 327 
In conclusion, our study provides further insights into the heterogeneous findings of studies 328 
examining the cardio-metabolic benefits of reducing sitting time. Firstly, long-term intervention 329 
seems necessary to identify relevant changes. Secondly, if using primarily sitting-standing 330 
substitutions, these seemingly need to be large volume, and achieved without adversely 331 
impacting stepping. Finally, sitting should be replaced with ambulatory activity if benefits to 332 
fasting insulin levels are desired and for potentially greater benefits to other biomarkers as well.   333 
 334 
ACKNOWLEDGEMENTS  335 
We acknowledge and thank: the Stand Up Victoria study participants; staff involved at the 336 
Department of Human Services (particularly, Tony Vane and Megan Evans); Peacock Bros for 337 
assisting with the logistics; Parneet Sethi for her assistance with data processing; Dr Takemi 338 
19 
 
Sugiyama and Dr Sheleigh Lawler for their contribution to questionnaire development; and, 339 
project field staff (Glen Weisner, Mary Sandilands, Kirsten Marks, Lisa Willenberg, Cameron 340 
Johnson, Beth Howard, Stephanie Fletcher and Michael Wheeler). We also wish to acknowledge 341 
the assistance of the Department of Human Services liaison officers Sevasti Athiniotis and 342 
Valerie McRorie. The views expressed in this paper are those of the authors and not necessarily 343 
anyone in this acknowledgement list nor ACSM. The results of the study are presented clearly, 344 




1. Wilmot EG, Edwardson CL, Achana FA et al. Sedentary time in adults and the 347 
association with diabetes, cardiovascular disease and death: systematic review and meta-analysis. 348 
Diabetologia. 2012;55(11):2895-905. 349 
2. Healy GN, Matthews CE, Dunstan DW, Winkler EA, Owen N. Sedentary time and 350 
cardio-metabolic biomarkers in US adults: NHANES 2003-06. European heart journal. 351 
2011;32(5):590-7. 352 
3. Pulsford RM, Blackwell J, Hillsdon M, Kos K. Intermittent walking, but not standing, 353 
improves postprandial insulin and glucose relative to sustained sitting: A randomised cross-over 354 
study in inactive middle-aged men. Journal of Science and Medicine in Sport. 2017;20(3):278-355 
83. 356 
4. Dempsey PC, Owen N, Yates TE, Kingwell BA, Dunstan DW. Sitting Less and Moving 357 
More: Improved Glycaemic Control for Type 2 Diabetes Prevention and Management. Current 358 
Diabetes Reports. 2016;16(11):114. 359 
5. Grace MS, Dempsey PC, Sethi P et al. Breaking Up Prolonged Sitting Alters the 360 
Postprandial Plasma Lipidomic Profile of Adults With Type 2 Diabetes. The Journal of clinical 361 
endocrinology and metabolism. 2017;102(6):1991-9. 362 
6. Healy GN, Lawler SP, Thorp A et al. Reducing prolonged sitting in the workplace (An 363 
evidence review: full report). Melbourne, Australia: Victorian Health Promotion 364 
Foundation2012. Available from: Victorian Health Promotion Foundation. 365 
7. Plotnikoff R, Healy G, Morgan P, Gilson N, Kennedy S. Action area 2 - Workplaces: 366 
Promote physical activity before, during and after work In. Blueprint for an active Australia: 367 
Government and community actions to increase population levels of physical activity and reduce 368 
21 
 
sedentary behaviour in Australia, 2014–2017 Melbourne, VIC Australia National Heart 369 
Foundation of Australia 2014, pp. 20-5. 370 
8. Neuhaus M, Eakin EG, Straker L et al. Reducing occupational sedentary time: a 371 
systematic review and meta-analysis of evidence on activity-permissive workstations. Obesity 372 
reviews : an official journal of the International Association for the Study of Obesity. 373 
2014;15(10):822-38. 374 
9. Alkhajah TA, Reeves MM, Eakin EG, Winkler EA, Owen N, Healy GN. Sit-stand 375 
workstations: a pilot intervention to reduce office sitting time. Am J Prev Med. 2012;43(3):298-376 
303. 377 
10. Healy GN, Eakin EG, Lamontagne AD et al. Reducing sitting time in office workers: 378 
short-term efficacy of a multicomponent intervention. Prev Med. 2013;57(1):43-8. 379 
11. Danquah IH, Kloster S, Holtermann A et al. Take a Stand!-a multi-component 380 
intervention aimed at reducing sitting time among office workers-a cluster randomized trial. 381 
International journal of epidemiology. 2016. 382 
12. Koepp GA, Manohar CU, McCrady-Spitzer SK et al. Treadmill desks: A 1-year 383 
prospective trial. Obesity. 2013;21(4):705-11. 384 
13. John D, Thompson DL, Raynor H, Bielak K, Rider B, Bassett DR. Treadmill 385 
workstations: a worksite physical activity intervention in overweight and obese office workers. J 386 
Phys Act Health. 2011;8(8):1034-43. 387 
14. Gomersall SR, Maher C, English C et al. Testing the activitystat hypothesis: a 388 
randomised controlled trial. BMC Public Health. 2016;16(1):900. 389 
15. Chastin SFM, Palarea-Albaladejo J, Dontje ML, Skelton DA. Combined Effects of Time 390 
Spent in Physical Activity, Sedentary Behaviors and Sleep on Obesity and Cardio-Metabolic 391 
22 
 
Health Markers: A Novel Compositional Data Analysis Approach. PLoS One. 392 
2015;10(10):e0139984. 393 
16. Dunstan DW, Wiesner G, Eakin EG et al. Reducing office workers' sitting time: rationale 394 
and study design for the Stand Up Victoria cluster randomized trial. BMC Public Health. 395 
2013;13(1):1057. 396 
17. Neuhaus M, Healy GN, Fjeldsoe BS et al. Iterative development of Stand Up Australia: a 397 
multi-component intervention to reduce workplace sitting. The international journal of 398 
behavioral nutrition and physical activity. 2014;11:21. 399 
18. Healy GN, Eakin EG, Owen N et al. A Cluster RCT to Reduce Office Workers' Sitting 400 
Time: Impact on Activity Outcomes. Med Sci Sports Exerc. 2016. 401 
19. Healy GN, Winkler EA, Eakin EG et al. A Cluster RCT to Reduce Workers' Sitting 402 
Time: Impact on Cardiometabolic Biomarkers. Med Sci Sports Exerc. 2017. 403 
20. Wijndaele K, Healy GN, Dunstan DW et al. Increased cardiometabolic risk is associated 404 
with increased TV viewing time. Medicine and Science in Sports and Exercise. 2010;42(8):1511-405 
8. 406 
21. Grant PM, Ryan CG, Tigbe WW, Granat MH. The validation of a novel activity monitor 407 
in the measurement of posture and motion during everyday activities. British journal of sports 408 
medicine. 2006;40(12):992-7. 409 
22. Chastin SFM, Winkler EAH, Eakin EG et al. Sensitivity to Change of Objectively-410 
Derived Measures of Sedentary Behavior. Measurement in Physical Education and Exercise 411 
Science. 2015;19(3):138-47. 412 
23. van den Boogaart KG, Tolosana-Delgado R. Analyzing Compositional Data with R. 413 
Berlin: Springer Berlin Heidelberg; 2013. 414 
23 
 
24. Aitchison J, Ng KW. The role of perturbation in compositional data analysis. Statistical 415 
Modelling. 2005;5(2):173-85. 416 
25. Buckley JP, Hedge A, Yates T et al. The sedentary office: a growing case for change 417 
towards better health and productivity. Expert statement commissioned by Public Health 418 
England and the Active Working Community Interest Company. British Journal of Sports 419 
Medicine. 2015;49(21):1357. 420 
26. Healy GN, Winkler EA, Owen N, Anuradha S, Dunstan DW. Replacing sitting time with 421 
standing or stepping: associations with cardio-metabolic risk biomarkers. European heart 422 
journal. 2015;36(39):2643-9. 423 
27. Judice PB, Hamilton MT, Sardinha LB, Zderic TW, Silva AM. What is the metabolic and 424 
energy cost of sitting, standing and sit/stand transitions? European journal of applied physiology. 425 
2016;116(2):263-73. 426 
28. Tikkanen O, Haakana P, Pesola AJ et al. Muscle activity and inactivity periods during 427 
normal daily life. PLoS One. 2013;8(1):e52228. 428 
29. Sale DG. Influence of exercise and training on motor unit activation. Exercise and sport 429 
sciences reviews. 1987;15:95-151. 430 
30. Coyle EF. Physical activity as a metabolic stressor. The American journal of clinical 431 
nutrition. 2000;72(2 Suppl):512s-20s. 432 
31. Bailey DP, Locke CD. Breaking up prolonged sitting with light-intensity walking 433 
improves postprandial glycemia, but breaking up sitting with standing does not. Journal of 434 
science and medicine in sport / Sports Medicine Australia. 2015;18(3):294-8. 435 
32. Pulsford RM, Blackwell J, Hillsdon M, Kos K. Intermittent walking, but not standing, 436 
improves postprandial insulin and glucose relative to sustained sitting: A randomised cross-over 437 
24 
 
study in inactive middle-aged men. Journal of science and medicine in sport / Sports Medicine 438 
Australia. 2016. 439 
 440 
  441 
25 
 
List of  Figures: Figure Captions 
 
Figure 1: Change in the composition of the waking day between baseline and 12 months. The 
centre shows no change, and each corner is a complete change in the activity (from 0% to 100% 
of the waking day). 
Figure 2: Predicted improvement in overall cardio-metabolic risk score (a, left) and insulin (b, 
right) by changes in the waking day’s composition (12 months). 
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